Evaluation of ClearLLab Leukemia and Lymphoma Panels

Completed

Conditions studied: Leukemia-Lymphoma

In brief

Multi-center study of specimens from subjects presenting to the flow cytometry laboratory as part of their standard of care for hematological diseases work-up.

Key facts

Study ID

NCT03413644

Run by

Beckman Coulter, Inc.

People needed

482

Starts

2017-11-14

Expected to finish

2018-04-27

Last updated by the study team

2018-07-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Residual samples from patients with hematological abnormalities being evaluated by Flow Cytometry for the presence or absence of an abnormal population associated with a hematological malignancy. All subjects of any ethnicity, age and racial background will be included.

You may not qualify if…

• Specimens and/or spent samples that are visibly hemolyzed
• Specimens and/or spent samples that are visibly clotted
• Specimens and/or spent samples collected in K2EDTA anticoagulant older than 24 hours from time of collection
• Specimens and/or spent samples collected in Heparin or ACD anticoagulant older than 48 hours from time of collection
• Samples with insufficient volume to complete the protocol tests

Where it is running

• NeoGenomics Laboratories, Inc. — Fort Myers, Florida, United States
• Calgary Laboratory Services — Calgary, Alberta, Canada
• London Health Sciences Center — London, Ontario, Canada
• Munich Leukemia Laboratory — Munich, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.